Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: Study protocol

BMC Cardiovascular Disorders

Volumn 11, Issue , 2011, Pages

  Pita Fernández, Salvador ^a   Pértega Díaz, Sonia ^a   Valdés Cañedo, Francisco ^a   Seijo Bestilleiro, Rocío ^a   Seoane Pillado, Teresa ^a   Fernández Rivera, Constantino ^a   Alonso Hernández, Angel ^a   Lorenzo Aguiar, Dolores ^a   López Calviño, Beatriz ^a   López Muñiz, Andres ^a  

^a Hospital A Coruna   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DYSLIPIDEMIA OBESITY AND CARDIOVASCULAR RISK FUNCTION; EUROPEAN SYSTEMATIC CORONARY RISK EVALUATION EQUATION; FRAMINGHAM SCORE; GERONA HEART REGISTRY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MORBIDITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SPAIN;

ADULT; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; SPAIN; SURVIVAL ANALYSIS;

EID: 78650966062     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-11-2     Document Type: Article

References (53)

1. Foley R, Parfrey P, Sarnak M. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998, 9(12 Suppl):S16-23.
2. Pilmore H, Dent H, Chang S, McDonald S, Chadban S. Reduction in cardiovascular death after kidney transplantation. Transplantation 2010, 89(7):851-857. 10.1097/TP.0b013e3181caeead, 20048695.
3. U.S. Renal Data System, USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2009, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
4. Kasiske B, Chakkera H, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000, 11(9):1735-1743.
5. Ojo A. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006, 82(5):603-611. 10.1097/01.tp.0000235527.81917.fe, 16969281.
6. Vanrenterghem Y, Claes K, Montagnino G, Fieuws S, Maes B, Villa M, Ponticelli C. Risk factors for cardiovascular events after successful renal transplantation. Transplantation 2008, 85(2):209-216. 10.1097/TP.0b013e318160254f, 18212625.
7. Cosio F, Alamir A, Yim S, Pesavento T, Falkenhain M, Henry M, Elkhammas E, Davies E, Bumgardner G, Ferguson R. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998, 53(3):767-772. 10.1046/j.1523-1755.1998.00787.x, 9507225.
8. Aalten J, Hoogeveen E, Roodnat J, Weimar W, Borm G, de Fijter J, Hoitsma A. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death. Transpl Int 2008, 21(10):985-991. 10.1111/j.1432-2277.2008.00717.x, 18564985.
9. Fellström B, Jardine A, Soveri I, Cole E, Grönhagen-Riska C, Neumayer H, Maes B, Gimpelewicz C, Holdaas H. Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial. Transplantation 2005, 79(9):1160-1163.
10. Forsythe J. Graft function and other risk factors as predictors of cardiovascular disease outcome. Transplantation 2001, 72(6 Suppl):S16-19.
11. Meier-Kriesche H, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003, 75(8):1291-1295. 10.1097/01.TP.0000061602.03327.E2, 12717218.
12. Massy Z, Chadefaux-Vekemans B, Chevalier A, Bader C, Drüeke T, Legendre C, Lacour B, Kamoun P, Kreis H. Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994, 9(8):1103-1108.
13. Friedman A, Rosenberg I, Selhub J, Levey A, Bostom A. Hyperhomocysteinemia in renal transplant recipients. Am J Transplant 2002, 2(4):308-313. 10.1034/j.1600-6143.2002.20404.x, 12118851.
14. Ducloux D, Motte G, Massy Z. Hyperhomocyst(e)inemia as a risk factor after renal transplantation. Ann Transplant 2001, 6(4):40-42.
15. Bertoni E, Marcucci R, Zanazzi M, Rosati A, Brunelli T, Fedi S, Pepe G, Di Maria L, Colonna F, Lombardi A, et al. Hyperhomocysteinemia in renal transplant patients: an independent factor of cardiovascular disease. J Nephrol 2001, 14(1):36-42.
16. Ducloux D, Kazory A, Chalopin J. Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int 2004, 66(1):441-447. 10.1111/j.1523-1755.2004.00751.x, 15200454.
17. Varagunam M, Finney H, Trevitt R, Sharples E, McCloskey D, Sinnott P, Raftery M, Yaqoob M. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis 2004, 43(3):502-507. 10.1053/j.ajkd.2003.11.011, 14981609.
18. Bakri R, Afzali B, Covic A, Sriskantharan R, Bharma-Ariza P, Park W, Sriharan M, Dalton N, Wierzbicki A, Crook M, et al. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Clin Transplant 2004, 18(2):201-204. 10.1111/j.1399-0012.2004.00156.x, 15016136.
19. Fernández-Fresnedo G, Escallada R, Rodrigo E, Piñera C, de Francisco A, Cotorruelo J, Sanz de Castro S, Arias M. Proteinuria is an independent risk factor of cardiovascular disease in renal transplant patient. Transplant Proc 2002, 34(1):367.
20. Fernández-Fresnedo G, Plaza J, Sánchez-Plumed J, Sanz-Guajardo A, Palomar-Fontanet R, Arias M. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 2004, 19(Suppl 3):iii47-51.
21. Roodnat J, Mulder P, Rischen-Vos J, van Riemsdijk I, van Gelder T, Zietse R, IJzermans J, Weimar W. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 2001, 72(3):438-444. 10.1097/00007890-200108150-00014, 11502973.
22. Alonso A, Oliver J. Causes of death and mortality risk factors. Nephrol Dial Transplant 2004, 19(Suppl 3):iii8-10. 10.1093/ndt/gfh1007, 15192128.
23. de Mattos A, Prather J, Olyaei A, Shibagaki Y, Keith D, Mori M, Norman D, Becker T. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int 2006, 70(4):757-764. 10.1038/sj.ki.5001628, 16788687.
24. Aakhus S, Dahl K, Widerøe T. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 1999, 14(3):648-654. 10.1093/ndt/14.3.648, 10193814.
25. Kasiske B, Snyder J, Gilbertson D, Matas A. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003, 3(2):178-185. 10.1034/j.1600-6143.2003.00010.x, 12603213.
26. Chuang P, Gibney E, Chan L, Ho P, Parikh C. Predictors of cardiovascular events and associated mortality within two years of kidney transplantation. Transplant Proc 2004, 36(5):1387-1391. 10.1016/j.transproceed.2004.05.006, 15251339.
27. Fernández-Fresnedo G, Escallada R, de Francisco A, Rodrigo E, Zubimendi J, Ruiz J, Piñera C, Herraez I, Arias M. Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients. Transplant Proc 2003, 35(2):700.
28. Miller L. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002, 2(9):807-818. 10.1034/j.1600-6143.2002.20902.x, 12392286.
29. Arnol M, de Mattos A, Chung J, Prather J, Mittalhenkle A, Norman D. Late steroid withdrawal and cardiovascular events in kidney transplant recipients. Transplantation 2008, 86(12):1844-1848. 10.1097/TP.0b013e31818ffec0, 19104432.
30. Anderson K, Wilson P, Odell P, Kannel W. An updated coronary risk profile. A statement for health professionals. Circulation 1991, 83(1):356-362.
31. Wilson P, D'Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847.
32. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, Ramos R, Sala J, Masià R, Rohlfs I, et al. [Coronary risk estimation in Spain using a calibrated Framingham function]. Rev Esp Cardiol 2003, 56(3):253-261. 10.1157/13043951, 12622955.
33. Conroy R, Pyörälä K, Fitzgerald A, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24(11):987-1003. 10.1016/S0195-668X(03)00114-3, 12788299.
34. Aranceta J, Pérez Rodrigo C, Foz Sala M, Mantilla T, Serra Majem L, Moreno B, Monereo S, Millán J. [Tables of coronary risk evaluation adapted to the Spanish population: the DORICA study]. Med Clin (Barc) 2004, 123(18):686-691. 10.1157/13068847, 15563815.
35. Kiberd B, Panek R. Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited. Clin J Am Soc Nephrol 2008, 3(3):822-828. 10.2215/CJN.00030108, 2386708, 18322053.
36. Kasiske B, Maclean J, Snyder J. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 2006, 17(3):900-907. 10.1681/ASN.2005090984, 16481414.
37. Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16(1):31-41. 10.1159/000180580, 1244564.
38. Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130(6):461-470.
39. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl 2):S1-113. 10.1097/01.hjr.0000277983.23934.c9, 17726407.
40. Brunzell J, Davidson M, Furberg C, Goldberg R, Howard B, Stein J, Witztum J, Association AD, . Foundation ACoC Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008, 31(4):811-822. 10.2337/dc08-9018, 18375431, Foundation ACoC.
41. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994, 89(3):1333-1445.
42. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993, 269(23):3015-3023. 10.1001/jama.269.23.3015, 8501844.
43. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153(2):154-183. 10.1001/archinte.153.2.154, 8422206.
44. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24(17):1601-1610. 10.1016/S0195-668X(03)00347-6, 12964575.
45. Lobos J, Royo-Bordonada M, Brotons C, Alvarez-Sala L, Armario P, Maiques A, Mauricio D, Sans S, Villar F, Lizcano A, et al. [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: CEIPC 2008 Spanish adaptation]. Rev Esp Salud Publica 2008, 82(6):581-616. 10.1590/S1135-57272008000600002, 19180272.
46. Sans S, Fitzgerald A, Royo D, Conroy R, Graham I. [Calibrating the SCORE cardiovascular risk chart for use in Spain]. Rev Esp Cardiol 2007, 60(5):476-485. 10.1016/S1885-5857(07)60188-1, 17535758.
47. Valdés-Cañedo F, Pita-Fernández S, Seijo-Bestilleiro R, Pértega-Díaz S, Alonso-Hernández A, Cillero-Rego S, Fernández-Rivera C, Oliver-García J. Incidence of cardiovascular events in renal transplant recipients and clinical relevance of modifiable variables. Transplant Proc 2007, 39(7):2239-2241.
48. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annals of Statistics 1988, 16(3):1141-1154.
49. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA 1999, 94:496-509.
50. Harrell FJ, Califf R, Pryor D, Lee K, Rosati R. Evaluating the yield of medical tests. JAMA 1982, 247(18):2543-2546. 10.1001/jama.247.18.2543, 7069920.
51. Heagerty P, Lumley T, Pepe M. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000, 56(2):337-344. 10.1111/j.0006-341X.2000.00337.x, 10877287.
52. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15(4):361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4, 8668867.
53. Marcén R, Fernández-Rodriguez A, Rodríguez-Mendiola N, Ponte B, Galeano C, Villafruela J, Teruel J, Burgos F, Ortuño J. Evolution of rejection rates and kidney graft survival: a historical analysis. Transplant Proc 2009, 41(6):2357-2359.